Menu
Back to Journals » Drug Design, Development and Therapy » Volume 16
Review
Expanding the Clinical Use of CDK4/6 Inhibitors in the Treatment of Hormone Receptor-Positive, HER2-Negative Breast Cancer from Metastatic Setting to Adjuvant Setting
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 6,478 | Dovepress* | 5,315+ | 372 | 5,687 | |
| PubMed Central* | 1,163 | 321 | 1,484 | ||
| Totals | 6,478 | 693 | 7,171 | ||
| *Since 16 March 2022 | |||||
View citations on PubMed Central and Google Scholar